Anhui Anke Biotechnology (Group) マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Lihua Song

最高経営責任者

CN¥2.7m

報酬総額

CEO給与比率	n/a
CEO在任期間	31.5yrs
CEOの所有権	26.6%
経営陣の平均在職期間	1.3yrs
取締役会の平均在任期間	3.4yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Lihua Song (67 yo)

31.5yrs

在職期間

CN¥2,712,000

報酬

Mr. Song Lihua serves as the Chairman of the Board and President at Anhui Anke Biotechnology (Group) Co., Ltd and its Director since May 1, 1993.

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Lihua Song	Chairman of Board of Directors & President	no data	CN¥2.71m	26.57% CN¥ 4.1b
Chenghao Hu	Financial Director	less than a year	CN¥438.70k	0.0024% CN¥ 373.3k
Jian Ping Yao	Executive President	no data	CN¥857.00k	0.40% CN¥ 63.2m
Hai Sheng	Senior Vice President	no data	CN¥1.11m	0.23% CN¥ 35.9m
Hui Zhao	Senior VP & Director	no data	CN¥651.00k	0.61% CN¥ 95.6m
Chunyan Lu	Vice President	less than a year	CN¥506.00k	0.020% CN¥ 3.1m
Yuanyuan Zhou	VP & Director	2.4yrs	CN¥635.00k	0.13% CN¥ 20.6m
Hongyi Yao	Vice President	1.7yrs	CN¥531.00k	0.048% CN¥ 7.5m
Xueke Bao	Vice President	less than a year	CN¥1.10m	0.025% CN¥ 3.9m
Yinghui Dou	Vice President	1.9yrs	CN¥687.00k	0.024% CN¥ 3.7m
Tawei Chou	Vice President	less than a year	CN¥887.00k	0.0087% CN¥ 1.4m
Kun Li	Secretary of the Board & Director	4.9yrs	CN¥469.00k	0.022% CN¥ 3.4m

1.3yrs

平均在職期間

49.5yo

平均年齢

経験豊富な経営陣: 300009の経営陣は経験豊富とはみなされません ( 1.3年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称	ポジション	在職期間	報酬	所有権
Lihua Song	Chairman of Board of Directors & President	31.5yrs	CN¥2.71m	26.57% CN¥ 4.1b
Hui Zhao	Senior VP & Director	17.6yrs	CN¥651.00k	0.61% CN¥ 95.6m
Yuanyuan Zhou	VP & Director	1.9yrs	CN¥635.00k	0.13% CN¥ 20.6m
Kun Li	Secretary of the Board & Director	1.9yrs	CN¥469.00k	0.022% CN¥ 3.4m
Xian Yu Du	Director	less than a year	CN¥72.00k	0.039% CN¥ 6.1m
Li Ming Song	Vice Chairman of the Board	21.3yrs	CN¥976.00k	6.87% CN¥ 1.1b
Yong Bin Wang	Director	11yrs	CN¥501.00k	0.072% CN¥ 11.2m
Guang Fu Liu	Independent Director	4.9yrs	CN¥75.00k	データなし
Wei Dong Zhu	Independence Director	4.9yrs	CN¥75.00k	データなし
Junpei Jiang	Director	1.9yrs	CN¥501.50k	0.058% CN¥ 9.1m
Feihu Chen	Independent Director	1.9yrs	CN¥75.00k	データなし
Xiaoping Geng	Independent Director	1.9yrs	CN¥75.00k	データなし

3.4yrs

平均在職期間

59yo

平均年齢

経験豊富なボード: 300009の取締役会は経験豊富であると考えられます ( 3.4年の平均在任期間)。

Anhui Anke Biotechnology (Group) マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Anhui Anke Biotechnology (Group) Co., Ltd., Annual General Meeting, Apr 18, 2024

Less than half of directors are independent

Anhui Anke Biotechnology (Group) Co., Ltd. Announces Board Elections

Less than half of directors are independent

Less than half of directors are independent

Anhui Anke Biotechnology (Group) Co., Ltd., Annual General Meeting, Apr 20, 2022

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.15 in 3Q 2023)

Investor sentiment deteriorates as stock falls 16%

Anhui Anke Biotechnology (Group) Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.13 in 2Q 2023)

Anhui Anke Biotechnology (Group) Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024

Dividend of CN¥0.25 announced

First quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.11 in 1Q 2023)

Anhui Anke Biotechnology (Group) Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Anhui Anke Biotechnology (Group) Co., Ltd., Annual General Meeting, Apr 18, 2024

Full year 2023 earnings released: EPS: CN¥0.51 (vs CN¥0.43 in FY 2022)

Investor sentiment improves as stock rises 20%

Anhui Anke Biotechnology (Group) Co., Ltd. to Report Fiscal Year 2023 Results on Mar 28, 2024

Less than half of directors are independent

Third quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.15 in 3Q 2022)

Anhui Anke Biotechnology (Group) Co., Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.10 in 2Q 2022)

Full year 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.13 in FY 2021)

Anhui Anke Biotechnology (Group) Co., Ltd. Announces Board Elections

Investor sentiment improved over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.11 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.075 in 2Q 2021)

Anhui Anke Biotechnology (Group) Co., Ltd. Announces Cash Dividend for the Year 2021, Payable on 13 May 2022

First quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.075 in 1Q 2021)

Less than half of directors are independent

Anhui Anke Biotechnology (Group) Co., Ltd. Approves Profit Distribution

Full year 2021 earnings released: EPS: CN¥0.13 (vs CN¥0.22 in FY 2020)

Anhui Anke Biotechnology (Group) Co., Ltd., Annual General Meeting, Apr 20, 2022

Anhui Anke Biotechnology (Group) Co., Ltd. Proposes Final Cash Dividend for the Year 2021

Anhui Anke Biotechnology (Group) Co., Ltd. (SZSE:300009) announces an Equity Buyback for CNY 60 million worth of its shares.

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.084 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.075 (vs CN¥0.049 in 2Q 2020)

Investor sentiment deteriorated over the past week

Anhui Anke Biotechnology (Group) Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented for 2020 (A Shares), Payable on 14 May 2021

First quarter 2021 earnings released: EPS CN¥0.09 (vs CN¥0.062 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.26 (vs CN¥0.092 in FY 2019)

Anhui Anke Biotechnology (Group) Co., Ltd. to Report Fiscal Year 2020 Results on Apr 08, 2021

New 90-day low: CN¥13.69

New 90-day low: CN¥14.64

New 90-day low: CN¥14.71

New 90-day low: CN¥15.69

Third quarter earnings released

Earnings released

New 90-day high - CN¥21.53

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /14